HB 5881 Summary

• Removes the restriction limiting auto-injectable epinephrine storage and use requirements to only certain authorized entities, applying requirements to all authorized entities that stock epinephrine.

• Requires authorized entities to designate an employee or agent who completes anaphylaxis training to oversee storage, maintenance, and oversight of auto-injectable epinephrine supplies.

• Mandates initial anaphylaxis training and biennial refresher training conducted by nationally recognized organizations or Department of Health and Human Services-approved providers, covering symptom recognition, storage/administration standards, and emergency procedures.

• Provides liability protection for authorized entities, employees, agents, trained individuals, and training providers who act in compliance with requirements, except in cases of willful or wanton misconduct.

• Allows authorized entities to make epinephrine available to untrained individuals through remote authorization by authorized health care providers via audio, televideo, or similar electronic communication, stored in locked secure containers.